Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

3.960 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45
Open 3.960
Bid (Size) 3.930 (25)
Ask (Size) 3.960 (8)
Prev. Close 3.960
Today's Range 3.960 - 3.960
52wk Range 3.381 - 7.630
Shares Outstanding 264,305,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MannKind (MNKD) Q2 Revenue Rises 6%
Via The Motley Fool
Topics Intellectual Property World Trade
MannKind Announces $500M Financing Agreement With Blackstone After Q2 Revenue Miss: Retail Believes Stock Is ‘Ridiculously Undervalued’
Via Stocktwits

Performance

YTD
-40.0%
-40.0%
1 Month
+3.7%
+3.7%
3 Month
-9.1%
-9.1%
6 Month
-26.9%
-26.9%
1 Year
-26.0%
-26.0%

More News

Read More
MannKind Corp (NASDAQ:MNKD) Q2 2025 Earnings Miss Estimates, Shares Drop 3.8% in Pre-Market
Via Chartmill
Topics Earnings
MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement
From MannKind
Via GlobeNewswire
Earnings Scheduled For August 6, 2025
Via Benzinga
A Look Ahead: MannKind's Earnings Forecast
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
MannKind's Earnings Outlook
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
MannKind Corporation Reports Second Quarter 2025 Financial Results And Provides Business Update
From MannKind
Via GlobeNewswire
MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025
From MannKind
Via GlobeNewswire
Top 3 Health Care Stocks That May Rocket Higher This Quarter
Via Benzinga
MannKind to Highlight Data from Recent Pediatric and Adult Studies of Inhaled Insulin (Afrezza®) at American Diabetes Association’s 85th Scientific Sessions in Chicago, June 20-23
From MannKind
Via GlobeNewswire
MannKind to Present at Upcoming Investor Conferences
From MannKind
Via GlobeNewswire
MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
From MannKind
Via GlobeNewswire
MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025
From MannKind
Via GlobeNewswire
This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Via Benzinga
MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options
From MannKind
Via GlobeNewswire
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22
From MannKind
Via GlobeNewswire
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’
Via Stocktwits
MannKind (MNKD) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
MannKind Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From MannKind
Via GlobeNewswire
MannKind Corporation to Hold 2024 Fourth Quarter and Full Year Financial Results Conference Call on February 26, 2025
From MannKind
Via GlobeNewswire
MannKind to Present at Upcoming Investor Conferences
From MannKind
Via GlobeNewswire
MannKind Expands Executive Leadership Team
From MannKind
Via GlobeNewswire

Frequently Asked Questions

Is MannKind Corporation - Common Stock publicly traded?
Yes, MannKind Corporation - Common Stock is publicly traded.
What exchange does MannKind Corporation - Common Stock trade on?
MannKind Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for MannKind Corporation - Common Stock?
The ticker symbol for MannKind Corporation - Common Stock is MNKD on the Nasdaq Stock Market
What is the current price of MannKind Corporation - Common Stock?
The current price of MannKind Corporation - Common Stock is 3.960
When was MannKind Corporation - Common Stock last traded?
The last trade of MannKind Corporation - Common Stock was at 08/19/25 04:00 PM ET
What is the market capitalization of MannKind Corporation - Common Stock?
The market capitalization of MannKind Corporation - Common Stock is 1.05B
How many shares of MannKind Corporation - Common Stock are outstanding?
MannKind Corporation - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.